Combination immunotherapy of αPD-1 and extended half-life IL-2 clears established GL261 gliomas in an MHC class I independent fashion
Year: 2020
Type: conference-abstract
Source: The Journal of Immunology
Institutions: Mayo Clinic, Massachusetts Institute of Technology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4313383138
